| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
Laboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, Departments of Medicine, Pharmacology, and Genetics, University of Pennsylvania School of Medicine and Abramson Cancer Center, Philadelphia, Pennsylvania 19104 [P. F. and W. S. E-D.], and Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104 [E. J. B.]
The in vivo response to radiotherapy is not well understood but appears to involve the p53 tumor suppressor protein. We investigated the expression of apoptosis-inducing p53 target genes during 
-irradiation-induced cell death in p53+/+ or p53-/- mouse tissues using in situ hybridization. Our results reveal striking tissue specificity with distinct regulation of target p53-induced genes in different cells and tissue compartments, as well as variations in dependence on p53 for basal expression. p53-dependent induction of Puma occurred in the splenic white pulp, whereas Noxa and Bid were induced in the red pulp. These patterns correlated with activation of caspase-3 in both compartments. All apoptotic targets of p53 studied here (DR5, Bid, Puma, Noxa) were induced in the jejunum and ileum, which appeared to be the tissues most sensitive to irradiation. We also observed unexpected differences in p53 target gene activation between the transverse and descending colon. Finally, in the liver where irradiation did not lead to caspase-3 activation, we primarily observed p21WAF1 induction as the major p53-dependent target gene response. Our findings indicate that the selectivity of p53 in transactivation following DNA damage in vivo results in unique tissue and cell type specificity, which may correlate with growth arrest or variable sensitivity to -irradiation.
This article has been cited by other articles:
|
|
 |
|
  J. A. Bertout, A. J. Majmundar, J. D. Gordan, J. C. Lam, D. Ditsworth, B. Keith, E. J. Brown, K. L. Nathanson, and M. C. Simon HIF2{alpha} inhibition promotes p53 pathway activity, tumor cell death, and radiation responses PNAS, August 25, 2009; 106(34): 14391 - 14396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.J. Pearson and A. Sanchez Alvarado Regeneration, Stem Cells, and the Evolution of Tumor Suppression Cold Spring Harb Symp Quant Biol, January 15, 2009; (2009) sqb.2008.73.045v1. [Abstract] [PDF]
|
|
|
|
|
|
M. Mandal, K. M. Crusio, F. Meng, S. Liu, M. Kinsella, M. R. Clark, O. Takeuchi, and I. Aifantis Regulation of lymphocyte progenitor survival by the proapoptotic activities of Bim and Bid PNAS, December 30, 2008; 105(52): 20840 - 20845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Nam, M. K. Lee, and K. Sabapathy The tumour-suppressor p53 is not required for pancreatic cell death during diabetes and upon irradiation J. Physiol., January 15, 2008; 586(2): 407 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Feng, W. Hu, E. de Stanchina, A. K. Teresky, S. Jin, S. Lowe, and A. J. Levine The Regulation of AMPK {beta}1, TSC2, and PTEN Expression by p53: Stress, Cell and Tissue Specificity, and the Role of These Gene Products in Modulating the IGF-1-AKT-mTOR Pathways Cancer Res., April 1, 2007; 67(7): 3043 - 3053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Levesque and A. Eastman p53-based cancer therapies: is defective p53 the Achilles heel of the tumor? Carcinogenesis, January 1, 2007; 28(1): 13 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Dicker, A. P. Kater, C. E. Prada, T. Fukuda, J. E. Castro, G. Sun, J. Y. Wang, and T. J. Kipps CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53 Blood, November 15, 2006; 108(10): 3450 - 3457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Ekert, A. M. Jabbour, A. Manoharan, J. E. Heraud, J. Yu, M. Pakusch, E. M. Michalak, P. N. Kelly, B. Callus, T. Kiefer, et al. Cell death provoked by loss of interleukin-3 signaling is independent of Bad, Bim, and PI3 kinase, but depends in part on Puma Blood, September 1, 2006; 108(5): 1461 - 1468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Hamstra, M. S. Bhojani, L. B. Griffin, B. Laxman, B. D. Ross, and A. Rehemtulla Real-time Evaluation of p53 Oscillatory Behavior In vivo Using Bioluminescent Imaging. Cancer Res., August 1, 2006; 66(15): 7482 - 7489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Akhtar, Y. Geng, B. J. Klocke, C. B. Latham, A. Villunger, E. M. Michalak, A. Strasser, S. L. Carroll, and K. A. Roth BH3-only proapoptotic Bcl-2 family members Noxa and Puma mediate neural precursor cell death. J. Neurosci., July 5, 2006; 26(27): 7257 - 7264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yu, W. Yue, B. Wu, and L. Zhang PUMA Sensitizes Lung Cancer Cells to Chemotherapeutic Agents and Irradiation. Clin. Cancer Res., May 1, 2006; 12(9): 2928 - 2936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. K. Koblish, S. Zhao, C. F. Franks, R. R. Donatelli, R. M. Tominovich, L. V. LaFrance, K. A. Leonard, J. M. Gushue, D. J. Parks, R. R. Calvo, et al. Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo Mol. Cancer Ther., January 1, 2006; 5(1): 160 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Yang, J. Wang, C. Liu, W. E. Grizzle, S. Yu, S. Zhang, S. Barnes, W. J. Koopman, J. D. Mountz, R. P. Kimberly, et al. Cleavage of p53-Vimentin Complex Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Mediated Apoptosis of Rheumatoid Arthritis Synovial Fibroblasts Am. J. Pathol., September 1, 2005; 167(3): 705 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Grimberg, C. M. Coleman, T. F. Burns, B. P. Himelstein, C. J. Koch, P. Cohen, and W. S. El-Deiry p53-Dependent and p53-Independent Induction of Insulin-Like Growth Factor Binding Protein-3 by Deoxyribonucleic Acid Damage and Hypoxia J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3568 - 3574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Wu, W. Ding, A. Mirza, T. Van Arsdale, I. Wei, W. R. Bishop, A. Basso, T. McClanahan, L. Luo, P. Kirschmeier, et al. Integrative Genomics Revealed RAI3 Is a Cell Growth-promoting Gene and a Novel P53 Transcriptional Target J. Biol. Chem., April 1, 2005; 280(13): 12935 - 12943. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Finnberg, J. J. Gruber, P. Fei, D. Rudolph, A. Bric, S.-H. Kim, T. F. Burns, H. Ajuha, R. Page, G. S. Wu, et al. DR5 Knockout Mice Are Compromised in Radiation-Induced Apoptosis Mol. Cell. Biol., March 1, 2005; 25(5): 2000 - 2013. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Liu, H. Lu, Z. Jiang, A. Pastuszyn, and C.-a. A. Hu Apolipoprotein L6, a Novel Proapoptotic Bcl-2 Homology 3-Only Protein, Induces Mitochondria-Mediated Apoptosis in Cancer Cells Mol. Cancer Res., January 1, 2005; 3(1): 21 - 31. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wang and W. S. El-Deiry Inducible Silencing of KILLER/DR5 In vivo Promotes Bioluminescent Colon Tumor Xenograft Growth and Confers Resistance to Chemotherapeutic Agent 5-Fluorouracil Cancer Res., September 15, 2004; 64(18): 6666 - 6672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, A. Meng, H. Lang, S. A. Brown, J. L. Konopa, M. S. Kindy, R. A. Schmiedt, J. S. Thompson, and D. Zhou Activation of Nuclear Factor {kappa}B In vivo Selectively Protects the Murine Small Intestine against Ionizing Radiation-Induced Damage Cancer Res., September 1, 2004; 64(17): 6240 - 6246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Erster, M. Mihara, R. H. Kim, O. Petrenko, and U. M. Moll In Vivo Mitochondrial p53 Translocation Triggers a Rapid First Wave of Cell Death in Response to DNA Damage That Can Precede p53 Target Gene Activation Mol. Cell. Biol., August 1, 2004; 24(15): 6728 - 6741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Yahagi, H. Shimano, T. Matsuzaka, M. Sekiya, Y. Najima, S. Okazaki, H. Okazaki, Y. Tamura, Y. Iizuka, N. Inoue, et al. p53 Involvement in the Pathogenesis of Fatty Liver Disease J. Biol. Chem., May 14, 2004; 279(20): 20571 - 20575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Perry Mdm2 in the Response to Radiation Mol. Cancer Res., January 1, 2004; 2(1): 9 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. H. Maclean, U. B. Keller, C. Rodriguez-Galindo, J. A. Nilsson, and J. L. Cleveland c-Myc Augments Gamma Irradiation-Induced Apoptosis by Suppressing Bcl-XL Mol. Cell. Biol., October 15, 2003; 23(20): 7256 - 7270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. F. Burns, P. Fei, K. A. Scata, D. T. Dicker, and W. S. El-Deiry Silencing of the Novel p53 Target Gene Snk/Plk2 Leads to Mitotic Catastrophe in Paclitaxel (Taxol)-Exposed Cells Mol. Cell. Biol., August 15, 2003; 23(16): 5556 - 5571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Honma, Y. Ishii, Y. Yamamoto-Yamaguchi, T. Sassa, and K.-i. Asahi Cotylenin A, a Differentiation-inducing Agent, and IFN-{alpha} Cooperatively Induce Apoptosis and Have an Antitumor Effect on Human Non-Small Cell Lung Carcinoma Cells in Nude Mice Cancer Res., July 1, 2003; 63(13): 3659 - 3666. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
